Differential binding of guanabenz and its metabolites to cerebral ?2-receptors: The basis for a radioligand assay specific for the drug
- 1 January 1983
- journal article
- research article
- Published by Wiley in Drug Development Research
- Vol. 3 (1) , 91-99
- https://doi.org/10.1002/ddr.430030111
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Gas Chromatographic Determination of Guanabenz in Biological Fluids by Electron-Capture DetectionJournal of Pharmaceutical Sciences, 1982
- Displacement of [3H]clonidine binding by clonidine analogues in membranes from rat cerebral cortexEuropean Journal of Pharmacology, 1980
- Guanabenz Degradation Products and Stability AssayJournal of Pharmaceutical Sciences, 1979
- The effect of a series of clonidine analogues on [3H] clonidine binding in rat cerebral cortexBiochemical Pharmacology, 1979
- Guanabenz in essential hypertensionClinical Pharmacology & Therapeutics, 1977
- Guanabenz effects on blood pressure and noninvasive parameters of cardiac performance in patients with hypertensionClinical Pharmacology & Therapeutics, 1976
- Studies on the centrally mediated hypotensive activity of guanabenzEuropean Journal of Pharmacology, 1976
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973
- Inhibition of spontaneous sympathetic nerve activity by the antihypertensive agent Wy-8678Neuropharmacology, 1970
- 2,6-Dichlorobenzylidene amino guanidine acetate (Wy-8678). A new hypotensive agentCellular and Molecular Life Sciences, 1969